CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 102 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $342,218 | -33.5% | 58,599 | -23.7% | 0.27% | -37.9% |
| Q3 2022 | $515,000 | +60.4% | 76,801 | +0.6% | 0.43% | +58.0% |
| Q2 2022 | $321,000 | +23.9% | 76,354 | -0.5% | 0.27% | +60.2% |
| Q1 2022 | $259,000 | -3.7% | 76,749 | -10.2% | 0.17% | +8.9% |
| Q4 2021 | $269,000 | -24.4% | 85,483 | +1.3% | 0.16% | -35.7% |
| Q2 2021 | $356,000 | -13.4% | 84,368 | +2.4% | 0.24% | -21.0% |
| Q1 2021 | $411,000 | -57.0% | 82,402 | +9.1% | 0.31% | -60.8% |
| Q4 2020 | $955,000 | – | 75,533 | – | 0.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 2,610 | $620,000,000 | 6.47% |
| Parkman Healthcare Partners LLC | 1,124,072 | $4,732,000 | 1.74% |
| Kynam Capital Management, LP | 1,000,000 | $4,210,000 | 1.08% |
| EAM Investors, LLC | 850,647 | $3,581,000 | 0.87% |
| BVF INC/IL | 3,629,000 | $15,278,000 | 0.74% |
| EAM Global Investors LLC | 388,730 | $1,637,000 | 0.40% |
| RA Capital Management | 3,307,203 | $13,923,000 | 0.37% |
| Nantahala Capital Management | 1,659,840 | $6,988,000 | 0.35% |
| AWM Investment Company, Inc. | 504,661 | $2,125,000 | 0.34% |
| INGALLS & SNYDER LLC | 1,411,153 | $5,941,000 | 0.31% |